OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.11−0.06 (-5.13%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
OKYO Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was -$5.94M. The highest annual figure on record is -$1.20M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$5.94M | – |
| FY2025 | Mar 31, 2025 | -$1.81M | – |
| FY2024 | Mar 31, 2024 | -$9.49M | – |
| FY2023 | Mar 31, 2023 | -$7.70M | – |
| FY2022 | Mar 31, 2022 | -$5.47M | – |
| FY2021 | Mar 31, 2021 | -$1.60M | – |
| FY2020 | Mar 31, 2020 | -$1.20M | – |
See a number that looks wrong?